Hematology NewsFDA expands Promacta approval to include pediatric patientsAugust 24, 2015Bleeding DisordersPediatricsRare Diseases
Hematology NewsNovel triple therapy in ITP provides enduring responsesAugust 11, 2015Bleeding DisordersRare Diseases
Hematology NewsEltrombopag yields 40% response rate in pediatric immune thrombocytopeniaAugust 4, 2015PediatricsBleeding DisordersRare Diseases
Hematology NewsDrug-induced iron deficiency decreased congenital erythropoietic porphyria symptomsJuly 24, 2015Rare DiseasesBleeding Disorders
Hematology NewsDicloxacillin may cut INR levels in warfarin usersJuly 21, 2015ThrombosisBleeding Disorders
Hematology NewsWorld Federation of Hemophilia Seeks ProposalsJuly 6, 2015Rare DiseasesBleeding Disorders
Hematology NewsSurgical bleeding risk ‘remarkable’ with platelet disordersJune 26, 2015Bleeding Disorders
Hematology NewsStudy establishes protocol for perioperative dabigatran discontinuationJune 25, 2015Bleeding Disorders
Hematology NewsIdarucizumab reverses dabigatran’s anticoagulant effectsJune 24, 2015ThrombosisBleeding Disorders
Hematology NewsPromacta approved for pediatric treatment of chronic ITPJune 12, 2015Bleeding DisordersRare DiseasesPediatrics
Hematology NewsDDW: VIDEO: What we don’t know in the management of liver disease and coagulopathyMay 17, 2015GastroenterologyBleeding DisordersGastrointestinal Cancer
Hematology NewsFDA approves new formulation of deferasirox for iron chelationMarch 31, 2015Rare DiseasesMyelodysplastic SyndromeBleeding Disorders
Hematology NewsLentiviral gene therapy could prove useful for adults with hemophiliaMarch 4, 2015PediatricsRare DiseasesBleeding Disorders
Oncology PracticeJAK inhibitor more effective than standard therapy for polycythemia veraJanuary 28, 2015Lymphoma & Plasma Cell DisordersBleeding Disorders
